BioStock: Alligator’s mitazalimab data published in The Lancet Oncology
Alligator Bioscience’s phase II data with cancer immunotherapy mitazalimab have been published in The Lancet Oncology – one of the most prestigious and internationally trusted scientific journals in the world. BioStock spoke with Alligator’s CEO Søren Bregenholt to get his reaction.Read the article at biostock.se: Alligator’s mitazalimab data published in The Lancet Oncology - BioStock This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/